Quality of life in non-metastasic colorectal cancer patients in FOLFOX or XELOX therapy.
CONCLUSIONS: Patients with XELOX scheme referred to have worse emotionally status in the middle of the adjuvant treatment than patients treated with FOLFOX scheme and presented a worsening in items fatigue, nausea, vomiting, anorexia and diarrhoea.
PMID: 30848178 [PubMed - in process]
Source: Farmacia Hospitalaria - Category: Drugs & Pharmacology Authors: Sánchez-Gundín J, Fernández-Carballido AM, Torres-Suárez AI, Barreda-Hernández D Tags: Farm Hosp Source Type: research
More News: Anorexia | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Constipation | Diarrhoea | Drugs & Pharmacology | Eating Disorders & Weight Management | Insomnia | Statistics | Study